Summary
Summary Pre-clinical drug discovery
- Institution
- University Of East Anglia
Drug design and mechanisms of drug action - 1st semester Includes bullet points, key diagrams and images
[Show more]
Seller
Follow
Content preview
Preclinical Drug Discovery Target selection using SNPs (single nucleotide polymorphisms) and
GWAS (genome wide association studies) link SNPs to diseases
Target validation- In vivo evidence using animal models with disease,
knock out the gene but may be lethal, compensated or show any physical
symptoms
Target validation- In vitro evidence by creating tissue or cell models,
remove, over-express or under-express a gene. They avoid animals and
use simple organisms like yeast or cancer
High throughput screening (HTS)- tests compound with UV-vis,
fluorescence and radioactivity. Assays: enzyme (inhibitors/activators),
receptor assays (agonists/antagonists) and cell based
(pathways/genome)
Lead optimisations:
Identify SAR (structure activity relationships)- change in structure
changes activity
Identify pharmacophore- minimal feature essential for activity
Improve potency, selectivity, patent property and improve drug qualities
(metabolism, bioavailability and solubility)
Lipinski’s rule of 5- MW<500, H bond donors<5, H bond acceptors<10 and
log P<5
Log P- lipophilic compound are hydrophobic so insoluble or may bind too
strongly to plasma proteins. They tend to be metabolised faster so Log P
1.5-3 is typical
MW- increasing MW increases chance that sites get metabolised
H bond donors and acceptors- solvate in bulk water but must be
desolvated before absorbed through GI (requires energy). Donors have a
higher energy requirement than acceptors
Rotatable bonds<10 for bioavailability- flexibility allows binding to other
proteins (side effects) and rigidity locks it into the desired conformation
Total polar surface area<140A- high value means they’re too hydrophilic
Fraction of sp3 orbitals- number of sp3 carbons divided by total carbons
and Fsp3<0.4 is desired. Low value mean a flat compound with issues with
solubility and metabolism
Preclinical development- once optimisation phase is complete NCE (new
chemical entity) is developed
NCE- tests drug PK and PD in animal modes, 14 week safety study,
formulation studies and synthesis backup drugs
Toxicity- alkylating agents (halogens, epoxides, αβ unsaturated ketone
and quinones). Aromatic amines and thiocarbonyls can be metabolised to
toxic groups
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller alexd1. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for £2.99. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
75632 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy revision notes and other study material for 14 years now